CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-24 | SIEGAL JONATHAN Principal Accounting Officer | Option exercise 10b5-1 | +1,875 | 3,081 | ||
| 2025-02-24 | SIEGAL JONATHAN Principal Accounting Officer | Shares withheld for taxes 10b5-1 | −738 | $52.33 | $39K | 2,343 |
| 2025-02-24 | SIEGAL JONATHAN Principal Accounting Officer | Option exercise · Restricted Stock Unit 10b5-1 | +1,875 | 5,625 | ||
| 2025-02-20 | SIEGAL JONATHAN Principal Accounting Officer | Grant or award · Stock Option (Right to Buy) | +6,600 | 6,600 | ||
| 2025-02-20 | SIEGAL JONATHAN Principal Accounting Officer | Grant or award · Restricted Stock Unit | +6,160 | 6,160 | ||
| 2025-02-20 | Mahoney Karen Chief Human Resources Officer | Grant or award · Stock Option (Right to Buy) | +12,938 | 12,938 | ||
| 2025-02-20 | Flynn Sean C. Chief Legal Officer | Sale 10b5-1 | −3,835 | $57.32 | $220K | 756 |
| 2025-02-20 | Flynn Sean C. Chief Legal Officer | Grant or award · Stock Option (Right to Buy) 10b5-1 | +35,000 | 35,000 | ||
| 2025-02-20 | Flynn Sean C. Chief Legal Officer | Grant or award · Restricted Stock Unit 10b5-1 | +14,000 | 14,000 | ||
| 2025-02-20 | Halpin Michael Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +52,500 | 52,500 | ||
| 2025-02-20 | Halpin Michael Chief Operating Officer | Grant or award · Restricted Stock Unit | +21,000 | 21,000 | ||
| 2025-02-20 | Hopper Jonathan Mark Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2025-02-20 | Hopper Jonathan Mark Chief Medical Officer | Grant or award · Restricted Stock Unit | +14,000 | 14,000 | ||
| 2025-02-20 | Mara Joseph Anthony Jr Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +46,250 | 46,250 | ||
| 2025-02-20 | Mara Joseph Anthony Jr Chief Financial Officer | Grant or award · Restricted Stock Unit | +18,500 | 18,500 | ||
| 2025-02-20 | Colangelo Dominick President and CEO | Grant or award · Stock Option (Right to Buy) | +182,500 | 182,500 | ||
| 2025-02-20 | Colangelo Dominick President and CEO | Grant or award · Restricted Stock Unit | +73,000 | 73,000 | ||
| 2025-02-19 | SIEGAL JONATHAN Principal Accounting Officer | Sale 10b5-1 | −1,710 | $56.72 | $97K | 1,206 |
| 2025-02-19 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +1,750 | 64,590 | ||
| 2025-02-19 | Hopper Jonathan Mark Chief Medical Officer | Shares withheld for taxes | −853 | $57.78 | $49K | 63,737 |
Page 17 of 75 · 1,497 trades